Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/10/2023) announced the following list of price concessions for October 2023:

Please note the following two lines have been revised upwards following mid-month price changes reported by pharmacy owners, the revised prices are reflected in the table below:

Ropinirole 250microgram tablets
Ropinirole 500microgram tablets

Pack size
Price concession

Acamprosate 333mg gastro-resistant tablets

Amiloride 5mg tablets

Beclometasone 50micrograms/dose nasal spray

Brinzolamide 10mg/ml eye drops

Bumetanide 1mg tablets

Chlorphenamine 2mg/5ml oral solution sugar free

Clarithromycin 125mg/5ml oral suspension

Clotrimazole 500mg pessaries

Co-amilozide 5mg/50mg tablets

Frovatriptan 2.5mg tablets

Hydrocortisone 1% cream

Hydrocortisone 1% cream

Lamotrigine 50mg tablets

Lansoprazole 30mg orodispersible tablets

Lofepramine 70mg tablets

Mebeverine 200mg modified-release capsules

Mebeverine 50mg/5ml oral suspension sugar free

Mercaptopurine 50mg tablets

Methylphenidate 10mg tablets

Pregabalin 225mg capsules

Primidone 250mg tablets

Pyridostigmine bromide 60mg tablets

Rizatriptan 10mg orodispersible tablets sugar free

Ropinirole 250microgram tablets

Ropinirole 500microgram tablets

Solifenacin 5mg/5ml oral solution sugar free

Spironolactone 50mg tablets

Warfarin 3mg tablets

For the full list of price concessions granted so far for October 2023, please visit our webpage:

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated October Drug Tariff price. Please note that we cannot provide details of any generic products awaiting price concession approval from DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website ( To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.

The post October 2023 Price Concessions 3rd Update appeared first on Community Pharmacy England.